ERBB2 and rectal cancer: In this case, sequencing revealed ERBB2 copy number amplification and a missense mutation (exon 17: c.G2033A; p.R648Q), and immunohistochemical analysis demonstrated HER2 positivity (3+) in the rectal cancer specimen.